EBS ▼ -2.9% - Emergent BioSolutions Inc.
$EBS - Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
Emergent BioSolutions fell 2.9% despite receiving a standing offer from the Government of Canada for its NARCAN® nasal spray product. The award represents a supply agreement that could generate recurring revenue from Canadian health authorities. The market's negative reaction to this government contract news is unclear from the headline alone, though investors may have anticipated a larger deal or different terms.
31-AUG-2026 07:55 AM ET
Share this post
More filings for $EBS
EBS ▼ -0.2% - Emergent BioSolutions Inc.Sep 15, 2026EBS ▲ +0.3% - Emergent BioSolutions Inc.Sep 3, 2026EBS ▲ +4.8% - Emergent BioSolutions Inc.Sep 1, 2026EBS ▼ -2.9% - Emergent BioSolutions Inc.Aug 31, 2026$EBS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026$EBS SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026
View full $EBS filing history →💬 Comments
Loading comments…
Leave a comment
